Product NDC: | 0703-5079 |
Proprietary Name: | Hetastarch |
Non Proprietary Name: | Hetastarch |
Active Ingredient(s): | 6 g/100mL & nbsp; Hetastarch |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-5079 |
Labeler Name: | Teva Parenteral Medicines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BA740592 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090113 |
Package NDC: | 0703-5079-37 |
Package Description: | 12 BAG in 1 CARTON (0703-5079-37) > 500 mL in 1 BAG (0703-5079-31) |
NDC Code | 0703-5079-37 |
Proprietary Name | Hetastarch |
Package Description | 12 BAG in 1 CARTON (0703-5079-37) > 500 mL in 1 BAG (0703-5079-31) |
Product NDC | 0703-5079 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hetastarch |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20090113 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc |
Substance Name | HETASTARCH |
Strength Number | 6 |
Strength Unit | g/100mL |
Pharmaceutical Classes | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient] |